Latanoprost. Mais um colírio "milagroso" ou o medicamento anti-glaucomatoso do século?

Brik, Maurício

doi:10.5935/0004-2749.19980003

Texto completo disponível apenas em PDF.

REFERENCIAS BIBLIOGRAFICAS

¹ Higginbotham EJ. Editorial - Will Latanoprost Be the "Wonder" Drug of the 90's for the Treatment of Glaucoma. Arch Ophthalmol 1996;114(8):998-9.
² Sibayan SA, Latina MA, Sherwood ME, Flotte TJ. and White K. Apoptosis and Morphologic Changes in Drug-treated Trabecular Meshwork Cells in Vitro. Exp Eye Res 1998;66(5):521-9.
³ Weih LM, Van Newkirkr M, Me Carty CA and Taylor HR. Patterns of Glaucoma Medication in use in Urban and Rural Victoria. Aust NZJ Ophthalmol 1998;26(Suppl. 1): 12-815.
⁴ Sjoquist B, Basu S, Byding P, Bergh K and Stjernschantz J. The Pharmacokinetcs of a new Antiglaucoma Drug, Latanoprost, in the Rabbit. Drug Metab Dispos 1998;26(8):745-54.
⁵ Aim. A, Camras CB and Watson PG. Phase III Latanoprost Studies in Scandinavia, the Unived Kingdom and the United States. Surv Ophthalmol 1997;41(Suppl 2):S105-S110.
⁶ Diestelhorst M and Almegard B. Comparison of two Fixed combinations of Latanoprost and Timolol in Open Angle Glaucoma. Graefes Arch Clin Exp Ophthalmol 1998;236(8):577-81.
⁷ Watson PG. Latanoprost. Two years' Experience of its use in the United Kingdom. Latanoprost Study Group. Ophthalmology 1998;105(l):82-7.
⁸ Rowe JA, Hattenhauere MG and Herman DC. Adverse Side Effects Associated with Latanoprost. Am J Ophthalmol 1997;124(5):683-5.
⁹ Hoyng PF, Rulo A, Greve E, Watson P and Aim A. The Additive intraocular Pressure-lowering Effect of Latanoprost in Combined Therapy with other Ocular Hypotensive Agents. Surv Ophthalmol 1997;41(Suppl. 2):S93-8.
¹⁰ Linden C and Aim A. Latanoprost and Physostigmine Have Mostly Additive Ocular Hypotensive Effects in Human Eyes. Arch Ophthalmol 1997;115(7):857-61.
¹¹ Diestelhorst M and Almegard B. Comparison of Two Fixed Combinations of Latanoprost and Timolol in Open-Angle Glaucoma. Graefes. Arch Clin Exp Ophthalmol 1998;236(8):577-81.
¹² Vanlandigham BD and Brubaker RF. Combined Effect of Dorzolamide and Latanoprost on the Rate of Aqueous Humour Flow. Amer J Ophthalmol 1998;126(2):191-6

Datas de Publicação

Publicação nesta coleção
Dez 1998

Este é um artigo publicado em acesso aberto (Open Access) sob a licença Creative Commons Attribution, que permite uso, distribuição e reprodução em qualquer meio, sem restrições desde que o trabalho original seja corretamente citado.

[1] ¹ Higginbotham EJ. Editorial - Will Latanoprost Be the "Wonder" Drug of the 90's for the Treatment of Glaucoma. Arch Ophthalmol 1996;114(8):998-9.

[2] ² Sibayan SA, Latina MA, Sherwood ME, Flotte TJ. and White K. Apoptosis and Morphologic Changes in Drug-treated Trabecular Meshwork Cells in Vitro. Exp Eye Res 1998;66(5):521-9.

[3] ³ Weih LM, Van Newkirkr M, Me Carty CA and Taylor HR. Patterns of Glaucoma Medication in use in Urban and Rural Victoria. Aust NZJ Ophthalmol 1998;26(Suppl. 1): 12-815.

[4] ⁴ Sjoquist B, Basu S, Byding P, Bergh K and Stjernschantz J. The Pharmacokinetcs of a new Antiglaucoma Drug, Latanoprost, in the Rabbit. Drug Metab Dispos 1998;26(8):745-54.

[5] ⁵ Aim. A, Camras CB and Watson PG. Phase III Latanoprost Studies in Scandinavia, the Unived Kingdom and the United States. Surv Ophthalmol 1997;41(Suppl 2):S105-S110.

[6] ⁶ Diestelhorst M and Almegard B. Comparison of two Fixed combinations of Latanoprost and Timolol in Open Angle Glaucoma. Graefes Arch Clin Exp Ophthalmol 1998;236(8):577-81.

[7] ⁷ Watson PG. Latanoprost. Two years' Experience of its use in the United Kingdom. Latanoprost Study Group. Ophthalmology 1998;105(l):82-7.

[8] ⁸ Rowe JA, Hattenhauere MG and Herman DC. Adverse Side Effects Associated with Latanoprost. Am J Ophthalmol 1997;124(5):683-5.

[9] ⁹ Hoyng PF, Rulo A, Greve E, Watson P and Aim A. The Additive intraocular Pressure-lowering Effect of Latanoprost in Combined Therapy with other Ocular Hypotensive Agents. Surv Ophthalmol 1997;41(Suppl. 2):S93-8.

[10] ¹⁰ Linden C and Aim A. Latanoprost and Physostigmine Have Mostly Additive Ocular Hypotensive Effects in Human Eyes. Arch Ophthalmol 1997;115(7):857-61.

[11] ¹¹ Diestelhorst M and Almegard B. Comparison of Two Fixed Combinations of Latanoprost and Timolol in Open-Angle Glaucoma. Graefes. Arch Clin Exp Ophthalmol 1998;236(8):577-81.

[12] ¹² Vanlandigham BD and Brubaker RF. Combined Effect of Dorzolamide and Latanoprost on the Rate of Aqueous Humour Flow. Amer J Ophthalmol 1998;126(2):191-6

Latanoprost. Mais um colírio "milagroso" ou o medicamento anti-glaucomatoso do século?

Latanoprost: another "wonder" drug or the antiglaucomatous medicine of the century?

REFERENCIAS BIBLIOGRAFICAS

Datas de Publicação